LGVN · Longeveron Inc
United States · RS rating 87 · As of 2026-10-14
| Price | 1.73 USD |
|---|---|
| 1-day change | -19.5% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 1 / 98 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 38 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +166.4% |
| Distance from 52-week high | +76.4% |
| Market cap (USD) | $28.6M |